Diffuse glomerulonephritis associated with rifampicin treatment for tuberculosis.
Yong
Jim L C
JL
Killingsworth
Murray C
MC
D000328:Adult; D000904:Antibiotics, Antitubercular / Q000009:adverse effects*; D015415:Biomarkers / Q000032:analysis; D005260:Female; D005921:Glomerulonephritis / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D007124:Immunoenzyme Techniques; D007678:Kidney Glomerulus / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D012293:Rifampin / Q000009:adverse effects*; D013601:T-Lymphocytes / Q000378:metabolism / Q000473:pathology; D014397:Tuberculosis, Pulmonary / Q000150:complications / Q000188:drug therapy*
D000904:Antibiotics, Antitubercular; D015415:Biomarkers; D012293:Rifampin